Abstract
Patients with Parkinson’s disease (PD) have deficits in perceptual timing, or the perception and estimation of time. PD patients can also have cognitive symptoms, including deficits in executive functions such as working memory, planning, and visuospatial attention. Here, we discuss how PD-related cognitive symptoms contribute to timing deficits. Timing is influenced by signaling of the neurotransmitter dopamine in the striatum. Timing also involves the frontal cortex, which is dysfunctional in PD. Frontal cortex impairments in PD may influence memory subsystems as well as decision processes during timing tasks. These data suggest that timing may be a type of executive function. As such, timing can be used to study the neural circuitry of cognitive symptoms of PD as they can be studied in animal models. Performance of timing tasks also maybe a useful clinical biomarker of frontal as well as striatal dysfunction in PD.
INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative disease where midbrain dopamine neurons inexorably die. Cardinal manifestations of PD include bradykinesia, rigidity, resting tremor, and postural instability. PD patients also have non-motor manifestations such as constipation, salivation, sleep disorders, mood disorders, and cognitive deficits (; Zesiewicz et al., 2010). Of these, executive dysfunction, one major domain of cognitive deficits in PD (Gotham et al., 1988; ; ), is associated with considerable morbidity (Williams-Gray et al., 2007) and predicts future mortality (Santangelo et al., 2007; Forsaa et al., 2010).
Executive dysfunction affects roughly 30% of PD patients (Williams-Gray et al., 2009; ). Deficits in executive tasks may define a disease trajectory, as cognitive symptoms are prognosticators of dementia onset (Mahieux et al., 1998; Levy et al., 2002a,b; Janvin et al., 2005). Such deficits can occur early in the disease (Foltynie et al., 2004; ) and involve impaired coordination of a range of cognitive processes required to achieve complex, goal-oriented, and novel cognitive operations (Elliott, 2003; Jurado and Rosselli, 2007). Executive processes include working memory, planning, inhibition, attention, and decreased speed of processing (Uc et al., 2005). These processes typically involve the frontal lobe (Fuster, 2008). These impairments are revealed using classic tests of executive function (Van Spaendonck et al., 1996) including verbal fluency, abstract reasoning, picture completion, Stroop performance (), and performance on the Tower-of-London task (Foltynie et al., 2004). Executive functions can include inhibitory control (Stuss et al., 2005; Picton et al., 2006) which may be impaired in PD (Wylie et al., 2010; Mirabella et al., 2013). Other executive processes such as action selection can be impaired in PD and correlate with dysfunctional frontostriatal networks (Hughes et al., 2013). Here, we are particularly interested in working memory aspects of executive function, as these appear to be involved in timing (Gibbon et al., 1984) and impaired in PD patients (Malapani et al., 1998).
Importantly, PD-related executive dysfunction is not directly correlated with motor dysfunction (Van Spaendonck et al., 1996), although it has been linked with gait-disturbance (Wylie et al., 2012). Dopaminergic therapy does not reliably improve executive dysfunction in high-functioning (Pascual-Sedano et al., 2008) or moderate PD patients (Morrison et al., 2004) and potentially can have detrimental effects (; ).
In addition to deficits in executive dysfunction, patients with PD consistently have impaired timing (e.g., ; O’Boyle et al., 1996; Malapani et al., 1998, 2002; Merchant et al., 2008; Jahanshahi et al., 2010; Jones et al., 2011). While some consider timing an executive function (Fuster, 2008), it is not universally considered as such (Elliott, 2003; Jurado and Rosselli, 2007). Executive functions classically involve goal-directed behavior such as planning, flexibility, problem solving, and attentional control (; Norman and Shallice, 1986; Lezak et al., 2004) rather than timing. In this review, we discuss evidence that (1) timing tasks involve executive processing in the frontal cortex, and (2) frontal dysfunction may contribute to timing deficits in PD patients.
PERCEPTUAL TIMING
Timing, i.e., the perception and estimation of time from seconds to minutes, is central in guiding a range of behaviors, from foraging and decision making to goal-directed behavior (). Perceptual timing at this scale can be measured using a variety of interval timing tasks. These tasks require subjects to make responses at precise times indicating their internal and subjective estimates of time. Interval timing is conserved across a wide range of species (), and is distinct from other measures such as motor timing, implicit timing, ordinal timing, and rhythmic timing.
In order to understand perceptual timing, it is useful to construct a detailed model which accounts both for timing behavior and errors in timing. Understanding the neural basis of timing models can be used to illuminate the mechanism of brain diseases which produce timing errors. One prominent model of timing is the scalar timing theory or scalar expectancy theory, also referred to as the pacemaker–accumulator model of timing (Gibbon et al., 1984). This model assumes the existence of a pacemaker that emits pulses at a certain rate, an accumulator that stores these pulses, and a decision module that constantly compares the accumulated pulses with an example sampled from memory. According to this model (Figure 1), a discriminative signal triggers the accumulation of the pulses, which are regularly compared with a randomly sampled number of pulses from the reference memory related to that discriminative signal. When the comparison crosses a threshold, a response is triggered (, ). Each component in this model produces variability, and at least of one these must be scalar, producing linearly increasing variance (Gibbon et al., 1984). Of note, there are alternative interval timing theories that, arguing for a lack of biological validity, do not assume the existence of a pacemaker/accumulator-type internal clock (; Laje and Buonomano, 2013); but see Simen et al. (2011) for a clock-like proposal of a neural model to estimate the passage of time). For instance, in a striatal beat–frequency model, striatal medium-spiny neurons serve as timers by detecting and integrating oscillatory states overtime (Matell et al., 2003; Meck et al., 2008; ). Of these, the scalar timing theory remains the most influential.
FIGURE 1
A link between interval timing and executive function is that classic tasks loading executive function impair interval timing (). For instance, remembering items interfered with subjects’ ability to reproduce temporal epochs (Fortin and Rousseau, 1998). When children were asked to both estimate time and perform other executive processes, they were impaired (Rattat, 2010). These type impairments in dual-task experiments suggest that increased dual-task allocation to executive processing resulted in a tradeoff with perceptual timing performance (). Interference seemed to be specifically constrained to the executive process of updating working memory buffers (Ogden et al., 2011). Taken together, these studies provide evidence that interval timing requires executive resources.
Perceptual timing has been reliably linked with dopamine signaling in the striatum (; Jones and Jahanshahi, 2013). Interval timing can activate medial frontal regions (Hinton et al., 2004; Jahanshahi et al., 2010), including supplementary and pre-supplementary areas (Mita et al., 2009; , ; Schneider and Ghose, 2012). Single neurons in medial prefrontal cortex are modulated by time (Niki and Watanabe, 1979; Meck et al., 2008; Genovesio et al., 2009; Narayanan and Laubach, 2009). Rodent studies using pharmacological and optogenetic methods have found that prefrontal D1 dopamine signaling is required for interval timing (Narayanan et al., 2012). A recent temporal discrimination task described that neuronal ensembles in rodent medial frontal cortex were modulated by the passage of time (Kim et al., 2013). These results suggest that interval timing and executive functions share similar neural networks.
Previous reviews have discussed the neuroanatomy of timing in great detail (Matell et al., 2003; ; Meck, 2006; ; ). A central structure in interval timing is the striatum (Harrington et al., 1998; Jones and Jahanshahi, 2013), likely favoring dorsal striatum (Kurti and Matell, 2011). However, timing can involve diverse and distributed brain networks (Meck et al., 2008; ). In Figure 1, we have illustrated potential brain networks that underlie timing-related processes suggested by the scalar timing theory. For instance, it is clear that the striatum influences all aspects of perceptual timing, from clock functions to decision and memory mechanisms (Husárová et al., 2011, 2013; ; Merchant et al., 2013). While temporal memory is certainly likely to involve frontal networks (Shimamura et al., 1990), recent reviews noted that medial frontal and medial premotor networks were consistently activated by perceptual timing tasks (; ). These areas might provide “context” (Merchant et al., 2013) and serve as executive control processes. Many of the frontal areas consistently activated include motor, supplementary motor, and cingulate cortex, which we posit are involved in the response decisions. Systematic recording and disruption experiments from this network in animal models will clarify the role of frontal cortex in memory vs. decision functions during interval timing.
DOPAMINE AND INTERVAL TIMING
The neurotransmitter dopamine is released from projections originating in the midbrain. Manipulations of dopaminergic signaling profoundly influence interval timing, leading to the hypothesis that dopamine influences internal pacemaker, or “clock,” activity (Maricq and Church, 1983; , ; Lake and Meck, 2013). For instance, amphetamine, which increases concentrations of dopamine at the synaptic cleft (Maricq and Church, 1983; Zetterström et al., 1983) advances the start of responding during interval timing (Taylor et al., 2007), whereas antagonists of D2 type dopamine receptors typically slow timing (Drew et al., 2003; Lake and Meck, 2013). Animal work has indicated that manipulations of both nigrostriatal (Drew et al., 2003, 2007; Meck, 2006) and mesocortical dopamine signaling originating from the ventral tegmental area (Narayanan et al., 2012) can also strongly influence interval timing.
In PD, midbrain projection neurons containing dopamine die (). PD patients are slow to initiate and execute movements (Evarts et al., 1981) and they also have impairments in interval timing. Early studies of PD patients off medication revealed a slowing of timing performance, which correlated with disease severity (; Pastor et al., 1992), and was consistent with bradykinesia observed with disease progression. Timing deficits were normalized by levodopa, and seem to be constrained to intervals on the scale of seconds (Koch et al., 2008). Notably, these patients had large variability in their estimates of time that was confirmed by a study in PD patients estimating two distinct intervals (Malapani et al., 1998). In this study, PD patients overestimated the short interval and underestimated the long interval; when they estimated the long interval only, they were slower. This effect, dubbed the “migration effect,” has been reliably found in PD patients (Koch et al., 2005). Timing deficits can be rescued by dopaminergic therapy (Malapani et al., 1998), suggesting that beyond clock speed, mnemonic representation for time is impaired in PD and that dopamine influences memory as well as clock subsystems.
Parkinson’s disease patients have timing impairments in related interval timing tasks. For instance, in a duration production and reproduction task with concurrent attentional loads, PD patients were more variable (Perbal et al., 2005). Both levodopa and stimulation of the subthalamic nucleus improved time reproduction (Torta et al., 2010). PD patients can also have deficits in processing temporal information at sub-second time scales (Harrington et al., 1998; Riesen and Schnider, 2001), but there is significant variability in timing at this scale (Merchant et al., 2008; Jones et al., 2011; ). The consistency of PD timing deficits at seconds and inconsistency below milliseconds may be related to the memory and attentional load of longer time intervals (Koch et al., 2008). PD patients consistently tend to have slower, more variable timing over a scale of seconds, which implies that the loss of dopamine influences not only clock deficits in PD patients, but memory and decision processes as well (Mehanna and Jankovic, 2013; Figure 1).
Notably, in some studies levodopa normalizes timing (Malapani et al., 1998; Koch et al., 2008) but not other executive functions such as memory, reasoning, or flexible learning (Gotham et al., 1988; ; Pascual-Sedano et al., 2008). Dopamine signaling may be complex with non-linearities (). Levodopa’s effects may also be influenced by disease severity (). Additionally, PD patients can be heterogeneous (Merchant et al., 2008; ) with respect to the disease.
Another possibility includes a role for non-dopaminergic signaling in PD-related cognitive dysfunction. Cortical and striatal areas are influenced by other broad neurotransmitter projection systems that are also impaired in PD, such as cholinergic projections originating from basal forebrain (). This area can be affected in PD patients (; Whitehouse et al., 1983; Fujita et al., 2006). Furthermore, clinical trials have demonstrated that cholinesterase inhibitor improves cognitive performance for PD patients with mild–moderate dementia (Emre et al., 2004; Poewe et al., 2006). Manipulations of cholinergic signaling (Meck and Church, 1987) and the basal forebrain (Olton et al., 1988) can strongly influence temporal memories. It is unclear if timing deficits are also improved in these patients.
Although PD also involves degeneration of many other brainstem projection nuclei (Scatton et al., 1983; ; Jellinger, 2011) such as serotonin and norepinephrine (McCormick et al., 1985), the role of these systems in executive dysfunction and perceptual timing deficits is unclear. However, because levodopa does not reliably treat PD-related cognitive symptoms (, ; Morrison et al., 2004; Pascual-Sedano et al., 2008), other non-dopaminergic mechanisms may be important for understanding cognition in PD. Future studies involving detailed correlation of neuropathology with clinical phenotypes as well as specific manipulations of non-dopaminergic systems in animal models will clarify this issue.
PD AND FRONTAL CORTEX
Deficits in interval timing have been uniformly interpreted as arising from deficits in nigrostriatal dopamine depletion affecting basal ganglia circuitry (; ). However, we note that PD can profoundly influence the function of frontal cortex. The source of cortical dopamine projections in the medial nigral and ventral tegmental midbrain (Williams and Goldman-Rakic, 1998) degenerate in PD (Javoy-Agid and Agid, 1980; Javoy-Agid et al., 1981; Dymecki et al., 1996). These studies suggest that ventral tegmental dopamine neurons degenerate to a lesser extent than the nearby substantia nigra, which primarily projects to the striatum. To date, the functional consequence of ventral tegmental degeneration is unclear (Jellinger, 1999), although there is debate about the involvement of ventral tegmental area in PD (Fearnley and Lees, 1991) likely because there is much overlap between these areas.
Midbrain dopamine neurons encode errors in temporal predictions of reward (Hollerman and Schultz, 1998; Fiorillo et al., 2008; Kobayashi and Schultz, 2008) and can precisely encode temporal information (Lapish et al., 2007). PD involves a dysfunction and loss of these neurons, which could lead to abnormalities in temporal processing in synaptic projection targets in the cortex and striatum. Without this input, these areas can be temporally desynchronized. Depletion of dopamine in healthy volunteers impairs timing (), while amphetamine releases synaptic dopamine and speeds up timing (Taylor et al., 2007). Animal models which record from both dopamine and downstream neurons or dynamically manipulate dopamine neurons while recording in downstream areas will identify the precise role that dopamine release has on temporal encoding in cortex and striatum.
Metabolic imaging demonstrates that PD patients have alterations in prefrontal dopamine signaling (Dubois and Pillon, 1995, 1997) which has been confirmed by positron emission tomography (PET with 18F-DOPA; Rakshi et al., 1999; Kaasinen et al., 2001). These studies have reported that in early PD, prefrontal dopamine uptake has been reported to be increased, presumably due to compensatory mechanisms. Dopamine influences executive function via mesocortical projections originating from the ventral tegmental area (; ). Prefrontal dopamine release measured by microdialysis is correlated with working memory performance (Phillips et al., 2004). Blocking prefrontal D1 receptors degrades the ability of prefrontal neurons to represent items in working memory (Williams and Goldman-Rakic, 1995; Goldman-Rakic et al., 2004; Wang et al., 2004). In rodent models, prefrontal D1 receptors are associated specifically with interval timing (Narayanan et al., 2012) as well as memory (Seamans et al., 1998; Floresco and Phillips, 2001). In addition, prefrontal dopamine signaling has been linked with a variety of cognitive behaviors, such as reasoning (Takahashi et al., 2012), attentional set-shifting (Floresco et al., 2006), reversal learning (Kehagia et al., 2010), impulsivity (Loos et al., 2010), and decision-making (Floresco, 2013). Dopamine release in prefrontal cortex can modulate network state (Seamans and Yang, 2004). These studies suggest that abnormalities in prefrontal dopamine signaling in PD could impair executive processing (Miller and Cohen, 2001).
Cognitive symptoms of PD appear can be linked with dysfunction in prefrontal networks. Deactivation in medial prefrontal cortex is associated with cognitive dysfunction in PD in metabolic imaging studies (Huang et al., 2007). Brain imaging studies in PD patients have found aberrant prefrontal networks. For example, controls activated medial frontal networks more reliably than PD patients during a task of random numbers generation (Dirnberger et al., 2005). Levodopa restored prefrontal blood flow as measured by PET during performance on a Tower-of-London task (). Decreased performance on attentional set-shifting by PD patients is correlated with less prefrontal metabolic activity (Sawada et al., 2012). This line of research suggests that there is executive dysfunction in PD that may involve the frontal cortex during timing tasks.
Several studies directly engage this question (Table 1). In a study of paced-finger tapping, less medial premotor as well as sensorimotor and cerebellar activity was observed in PD patients relative to controls (Elsinger et al., 2003). While on and off levodopa, Harrington et al. (2011) asked PD patients to perform a perceptual timing task, comparing two intervals of time while collecting functional magnetic resonance images (fMRI). This study found temporal impairments throughout frontostriatal and cerebellar networks, and found abnormal activations in medial frontal and parietal areas, which are typically associated with executive processes such as working memory. Activity in this network was abnormal while PD patients encoded time and absent during the decision phase; furthermore, in medial frontal areas such as the cingulate cortex, different temporal profiles were observed in concert with temporal alterations in the striatum. A study modeling effective connectivity found that in controls, medial supplementary motor areas had excitatory coupling with subcortical areas, while PD patients did not (Husárová et al., 2013). Some studies find no changes in this circuit in PD patients during timing tasks (; Praamstra and Pope, 2007); of note, this may be related to both disease and pathological heterogeneities in PD patients (Merchant et al., 2008; ). Nonetheless, PD patients with timing-related dysfunction have abnormalities in medial frontal areas (including supplementary motor areas) in addition to the basal ganglia and cerebellum.
Table 1
| Study | Task | Subjects | Hypoactive areas in PD patients |
|---|---|---|---|
| Harrington etal. (2011) | Time perception task | Controls PD patients on/and off | Middle frontal cortex/parietal cortex – temporal encoding striatal dysfunction – time keeping |
| Jahanshahi etal. (2010) | Finger tapping | Controls PD patients on/and off | No activation in medial frontal cortex, cingulate, hippocampus, accumbens during timing |
| Elsinger etal. (2003) | Finger tapping | Controls PD patients on/and off | Decreased activation in medial premotor cortex, sensorimotor cortex, and cerebellum |
| Internally timed movements | Controls PD patients on/and off | Similar supplementary motor and subcortical areas in PD patients OFFand controls | |
| Praamstra and Pope (2007) | Timed choice reaction time task | Controls vs. PD patients | Abnormal beta/alpha activity related to temporal preparation |
| Husárová etal. (2013) | Motor timing task | Controls vs. PD patients off | Similar area: supplementary motor, basal ganglia, cerebellum, putamen. PD patients had an inhibitory SMA-Cb connection. |
| Husárová etal. (2011) | Motor timing | Contols vs. PD patients off | Did not include cortical cuts; less basal ganglia/cerebellum in PD patients. |
Studies that examine the neuroanatomical basis of timing deficits and PD.
These data are supported with neurophysiological studies from animal models. For instance, in a temporal judgment task, primate prefrontal neurons predominantly encoded temporal duration (Genovesio et al., 2009). These same neurons were robustly modulated during the response window when a judgment was made. Similar patterns have also been observed in rodent frontal cortex (Narayanan and Laubach, 2006, 2009; Kim et al., 2013), and suggest that medial frontal cortex plays an essential role in encoding and judging temporal information.
Notably, the frontal cortex and striatum function together as a circuit (), and several of the preceding studies involved PD-related abnormalities in the striatum as well as the frontal cortex (Elsinger et al., 2003; Harrington et al., 2011; Husárová et al., 2011) which could be modulated by dopamine (Jahanshahi et al., 2010). Effective connectivity analyses suggest that striatal and cortical areas work together to guide behavior during timing tasks (Husárová et al., 2013). However, investigating the precise mechanistic relationships among areas in the frontal cortex and striatum would require recording from both areas simultaneously or inactivating one area and examining neural activity in the other. Intraoperative recording during deep-brain stimulation surgery (Sheth et al., 2012) or recording from animal models (Narayanan and Laubach, 2006) could investigate this question in detail.
Several investigators have suggested that timing deficits in PD may involve cognitive processing well beyond motor timing such as memory (Malapani et al., 1998; Koch et al., 2008). Imaging studies have captured deficits in control processing originating from medial regions of the frontal cortex (Jahanshahi et al., 2010; Harrington et al., 2011). These data suggest that interval timing and executive functions share resources in the medial frontal cortex, and that dysfunctional timing in Parkinson’s patients may involve frontal as well striatal circuitry.
There are two clear implications supporting this idea. First, interval timing may be a useful clinical tool to assess the integrity of the frontostriatal system (Wild-Wall et al., 2008). One could imagine a specific interval timing paradigm to assess perceptual timing with a range of intervals spanning milliseconds to several seconds targeted at assaying both motor timing and higher order processing. As such, this task could provide early detection of timing deficits. Such a test would be simple, readily added to a neuropsychological battery or even administered remotely (Sternberg et al., 2013) to assist in diagnosis of disease, screen for executive dysfunction, track disease progression, and/or response to therapy.
Secondly, perceptual timing tasks can be readily trained in animals () such as rodents () or pigeons (Ludvig et al., 2011). This enables detailed, mechanistic investigation of neural circuits underlying the temporal organization of motivated behavior with tools such as transgenic mice (Drew et al., 2007), optogenetics (Narayanan et al., 2012), and neuronal ensemble recording (Matell et al., 2003; Kim et al., 2013). These circuits can be investigated in detail to understand how frontostriatal circuits are involved in perceptual timing.
In summary, we have suggested that perceptual timing is a type of executive function. Considering it as such implies that testing perceptual timing is a useful way of testing cognitive function in PD patients. Detailed mechanistic understanding of the neural circuits involved in perceptual timing in PD could lead to a greater understanding of the cognitive symptoms of PD and to targeted therapies for this difficult clinical problem.
Statements
Acknowledgments
This work was supported by an NINDS K08 to Nandakumar S. Narayanan.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
REFERENCES
1
AarslandD.BrønnickK.FladbyT. (2011). Mild cognitive impairment in Parkinson’s disease.Curr. Neurol. Neurosci. Rep.11371–378. 10.1007/s11910-011-0203-1
2
AarslandD.BrønnickK.LarsenJ. P.TysnesO. B.AlvesG. (2009). Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.Neurology721121–1126. 10.1212/01.wnl.0000338632.00552.cb
3
AarslandD.BronnickK.Williams-GrayC.WeintraubD.MarderK.KulisevskyJ.et al (2010). Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.Neurology751062–1069. 10.1212/WNL.0b013e3181f39d0e
4
AarslandD.KurzM. W. (2010). The epidemiology of dementia associated with Parkinson’s disease.Brain Pathol.20633–639. 10.1111/j.1750-3639.2009.00369.x
5
AlexanderG. E.DeLongM. R.StrickP. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex.Annu. Rev. Neurosci.9357–381. 10.1146/annurev.ne.09.030186.002041
6
AllmanM. J.MeckW. H. (2012). Pathophysiological distortions in time perception and timed performance.Brain135656–677. 10.1093/brain/awr210
7
ArendtT.BiglV.ArendtA.TennstedtA. (1983). Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans and Korsakoff’s disease.Acta Neuropathol.61101–108. 10.1007/BF00697388
8
ArnstenA. F. T.LiB-M. (2005). Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.Biol. Psychiatry571377–1384. 10.1016/j.biopsych.2004.08.019
9
ArtiedaJ.PastorM. A.LacruzF.ObesoJ. A. (1992). Temporal discrimination is abnormal in Parkinson’s disease.Brain115199–210. 10.1093/brain/115.1.199
10
BaddeleyA.HitchG. (1974). Working Memory.New York: Academic Press.
11
BalciF.PapachristosE. B.GallistelC. R.BrunnerD.GibsonJ.ShumyatskyG. P. (2008). Interval timing in genetically modified mice: a simple paradigm.Genes Brain Behav.7373–384. 10.1111/j.1601-183X.2007.00348.x
12
BiglV.WoolfN. J.ButcherL. L. (1982). Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis.Brain Res. Bull.8727–749. 10.1016/0361-9230(82)90101-0
13
BrownS. W. (2006). Timing and executive function: bidirectional interference between concurrent temporal production and randomization tasks.Mem. Cogn.341464–1471. 10.3758/BF03195911
14
BrownS. W.CollierS. A.NightJ. C. (2012). Timing and executive resources: dual-task interference patterns between temporal production and shifting, updating, and inhibition tasks.J. Exp. Psychol. Hum. Percept. Perform.39947–963. 10.1037/a0030484
15
BuhusiC. V.MeckW. H. (2005). What makes us tick? Functional and neural mechanisms of interval timing.Nat. Rev. Neurosci6755–765. 10.1038/nrn1764
16
BuhusiC. V.MeckW. H. (2009). Relativity theory and time perception: single or multiple clocks?PLoS ONE4:e6268. 10.1371/journal.pone.0006268
17
BuhusiC. V.OprisanS. A. (2013). Time-scale invariance as an emergent property in a perceptron with realistic, noisy neurons.Behav. Processes9560–70. 10.1016/j.beproc.2013.02.015
18
CerasaA.HagbergG. E.PeppeA.BianciardiM.GioiaM. C.CostaA.et al (2006). Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson’s disease.Brain Res. Bull.71259–269. 10.1016/j.brainresbull.2006.09.014
19
ChaudhuriK. RSchapiraA. H. V. (2009). Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment.Lancet Neurol.8464–474. 10.1016/S1474-4422(09)70068-7
20
ChurchR. (2003). “A concise introduction to scalar timing theory,” inFunctional and Neural Mechanisms of Interval Timinged.MeckW. (New York: CRC Press) 3–22.
21
ChurchR. M. (1984). Properties of the internal clock.Ann. N.Y. Acad. Sci.423566–582. 10.1111/j.1749-6632.1984.tb23459.x
22
ChurchR. M. (1997). Quantitative models of animal learning and cognition.J. Exp. Psychol. Anim. Behav. Process.23379–389. 10.1037/0097-7403.23.4.379
23
ClaassenD. O.JonesC. R. G.YuM.DirnbergerG.MaloneT.ParkinsonM.et al (2013). Deciphering the impact of cerebellar and basal ganglia dysfunction in accuracy and variability of motor timing.Neuropsychologia51267–274. 10.1016/j.neuropsychologia.2012.09.018
24
CoolsR.BarkerR. A.SahakianB. J.RobbinsT. W. (2001). Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands.Cereb. Cortex111136–1143. 10.1093/cercor/11.12.1136
25
CoolsRD’EspositoM. (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control.Biol. Psychiatry69e113–e125. 10.1016/j.biopsych.2011.03.028
26
CoolsR.StefanovaE.BarkerR. A.RobbinsT. W.OwenA. M. (2002). Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET.Brain125584–594. 10.1093/brain/awf052
27
CooperJ. A.SagarH. J.JordanN.HarveyN. S.SullivanE. V. (1991). Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor disability.Brain 114(Pt5)2095–2122. 10.1093/brain/114.5.2095
28
CoullJ.NobreA. (2008). Dissociating explicit timing from temporal expectation with fMRI.Curr. Opin. Neurobiol.18137–144. 10.1016/j.conb.2008.07.011
29
CoullJ. T.ChengR.-K.MeckW. H. (2011). Neuroanatomical and neurochemical substrates of timing.Neuropsychopharmacology363–25. 10.1038/npp.2010.113
30
CoullJ. T.HwangH. J.LeytonM.DagherA. (2012). Dopamine precursor depletion impairs timing in healthy volunteers by attenuating activity in putamen and supplementary motor area.J. Neurosci.3216704–16715. 10.1523/JNEUROSCI.1258-12.2012
31
DamierP.HirschE. C.AgidY.GraybielA. M. (1999). The substantia nigra of the human brain II.Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain1221437–1448. 10.1093/brain/122.8.1437
32
Del TrediciK.RübU.De VosR. A. I.BohlJ. R. E.BraakH. (2002). Where does Parkinson disease pathology begin in the brain?J. Neuropathol. Exp. Neurol.61413–426.
33
DirnbergerG.FrithC. D.JahanshahiM. (2005). Executive dysfunction in Parkinson’s disease is associated with altered pallidal-frontal processing.Neuroimage25588–599. 10.1016/j.neuroimage.2004.11.023
34
DrewM. R.FairhurstS.MalapaniC.HorvitzJ. C.BalsamP. D. (2003). Effects of dopamine antagonists on the timing of two intervals.Pharmacol. Biochem. Behav.759–15. 10.1016/S0091-3057(03)00036-4
35
DrewM. R.SimpsonE. H.KellendonkC.HerzbergW. G.LipatovaO.FairhurstS.et al (2007). Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing.J. Neurosci.277731–7739. 10.1523/JNEUROSCI.1736-07.2007
36
DuboisB.PillonB. (1995). Do cognitive changes of Parkinson’s disease result from dopamine depletion?J. Neural Transm. Suppl.4527–34.
37
DuboisB.PillonB. (1997). Cognitive deficits in Parkinson’s disease.J. Neurol.2442–8. 10.1007/PL00007725
38
DymeckiJ.LechowiczW.BertrandE.SzpakG. M. (1996). Changes in dopaminergic neurons of the mesocorticolimbic system in Parkinson’s disease.Folia Neuropathol.34102–106.
39
ElliottR. (2003). Executive functions and their disorders.Br. Med. Bull.6549–59. 10.1093/bmb/65.1.49
40
ElsingerC. L.RaoS. M.ZimbelmanJ. L.ReynoldsN. C.BlindauerK. A.HoffmannR. G. (2003). Neural basis for impaired time reproduction in Parkinson’s disease: an fMRI study.J. Int. Neuropsychol. Soc.91088–1098. 10.1017/S1355617703970123
41
EmreM.AarslandD.AlbaneseA.ByrneE. J.DeuschlG.De DeynP. P.et al (2004). Rivastigmine for dementia associated with Parkinson’s disease.N. Engl. J. Med.3512509–2518. 10.1056/NEJMoa041470
42
EvartsE. V.TeräväinenH.CalneD. B. (1981). Reaction time in Parkinson’s disease.Brain104167–186. 10.1093/brain/104.1.167
43
FearnleyJ. M.LeesA. J. (1991). Ageing and Parkinson’s disease: substantia nigra regional selectivity.Brain1142283–2301. 10.1093/brain/114.5.2283
44
FiorilloC. D.NewsomeW. T.SchultzW. (2008). The temporal precision of reward prediction in dopamine neurons.Nat. Neurosci.11966–973. 10.1038/nn.2159
45
FlorescoS. B. (2013). Prefrontal dopamine and behavioral flexibility: shifting from an “inverted-U” toward a family of functions.Front. Neurosci.7:62.10.3389/fnins.2013.00062
46
FlorescoS. B.MagyarO.Ghods-SharifiS.VexelmanCTseM. T. L. (2006). Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting.Neuropsychopharmacology31297–309. 10.1038/sj.npp.1300825
47
FlorescoS. B.PhillipsA. G. (2001). Delay-dependent modulation of memory retrieval by infusion of a dopamine D1 agonist into the rat medial prefrontal cortex.Behav. Neurosci.115934–939. 10.1037/0735-7044.115.4.934
48
FoltynieT.BrayneC. E. G.RobbinsT. W.BarkerR. A. (2004). The cognitive ability of an incident cohort of Parkinson’s patients in the UK.The CamPaIGN study. Brain127550–560. 10.1093/brain/awh067
49
ForsaaE. B.LarsenJ. P.Wentzel-LarsenT.AlvesG. (2010). What predicts mortality in Parkinson disease? A prospective population-based long-term study.Neurology751270–1276. 10.1212/WNL.0b013e3181f61311
50
FortinC.RousseauR. (1998). Interference from short-term memory processing on encoding and reproducing brief durations.Psychol. Res.61269–276. 10.1007/s004260050031
51
FujitaM.IchiseM.ZoghbiS. S.LiowJ.-S.GhoseS.VinesD. C.et al (2006). Widespread decrease of nicotinic acetylcholine receptors in Parkinson’s disease.Ann. Neurol.59174–177. 10.1002/ana.20688
52
FusterJ. (2008). The Prefrontal Cortex, 4th Edn.New York, NY: Academic Press.
53
GenovesioA.TsujimotoS.WiseS. P. (2009). Feature- and order-based timing representations in the frontal cortex.Neuron63254–266. 10.1016/j.neuron.2009.06.018
54
GibbonJ.ChurchR. M.MeckW. H. (1984). Scalar timing in memory.Ann. N.Y. Acad. Sci.42352–77. 10.1111/j.1749-6632.1984.tb23417.x
55
Goldman-RakicP. S.CastnerS. A.SvenssonT. H.SieverL. J.WilliamsG. V. (2004). Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.Psychopharmacology (Berl.)1743–16. 10.1007/s00213-004-1793-y
56
GothamA. M.BrownR. G.MarsdenC. D. (1988). “Frontal” cognitive function in patients with Parkinson’s disease “on” and “off” levodopa.Brain111(Pt 2)299–321. 10.1093/brain/111.2.299
57
HarringtonD. L.CastilloG. N.GreenbergP. A.SongD. D.LessigS.LeeR. R.et al (2011). Neurobehavioral mechanisms of temporal processing deficits in Parkinson’s disease.PLoS ONE6:e17461. 10.1371/journal.pone.0017461
58
HarringtonD. L.HaalandK. Y.HermanowiczN. (1998). Temporal processing in the basal ganglia.Neuropsychology123–12. 10.1037/0894-4105.12.1.3
59
HintonS. C.HarringtonD. L.BinderJ. R.DurgerianS.RaoS. M. (2004). Neural systems supporting timing and chronometric counting: an FMRI study.Brain Res. Cogn. Brain Res.21183–192. 10.1016/j.cogbrainres.2004.04.009
60
HollermanJ. R.SchultzW. (1998). Dopamine neurons report an error in the temporal prediction of reward during learning.Nat. Neurosci.1304–309. 10.1038/1124
61
HuangC.MattisP.TangC.PerrineK.CarbonM.EidelbergD. (2007). Metabolic brain networks associated with cognitive function in Parkinson’s disease.Neuroimage34714–723. 10.1016/j.neuroimage.2006.09.003
62
HughesL. E.AltenaE.BarkerR. A.RoweJ. B. (2013). Perseveration and choice in Parkinson’s disease: the impact of progressive frontostriatal dysfunction on action decisions.Cereb. Cortex231572–1581. 10.1093/cercor/bhs144
63
HusárováI.LunguO. V.MarečekR.MiklM.GescheidtT.KrupaP.et al (2011). Functional imaging of the cerebellum and basal ganglia during predictive motor timing in early Parkinson’s disease.J. Neuroimaging 10.1111/j.1552-6569.2011.00663.x [Epub ahead of print].
64
HusárováI.MiklM.LunguO. V.MarečekR.VanïčekJBarešM. (2013). Similar circuits but different connectivity patterns between the cerebellum, basal ganglia, and supplementary motor area in early Parkinson’s disease patients and controls during predictive motor timing.J. Neuroimaging 10.1111/jon.12030 [Epub ahead of print].
65
JahanshahiM.JonesC. R. G.ZijlmansJ.KatzenschlagerR.LeeL.QuinnN.et al (2010). Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson’s disease.Brain133727–745. 10.1093/brain/awq012
66
JanvinC. C.AarslandD.LarsenJ. P. (2005). Cognitive predictors of dementia in Parkinson’s disease: a community-based, 4-year longitudinal study.J. Geriatr. Psychiatry Neurol.18149–154. 10.1177/0891988705277540
67
Javoy-AgidF.AgidY. (1980). Is the mesocortical dopaminergic system involved in Parkinson disease?Neurology301326–1330. 10.1212/WNL.30.12.1326
68
Javoy-AgidF.PloskaA.AgidY. (1981). Microtopography of tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains.J. Neurochem.371218–1227. 10.1111/j.1471-4159.1981.tb04672.x
69
JellingerK. A. (1999). Post mortem studies in Parkinson’s disease: is it possible to detect brain areas for specific symptoms?J. Neural Transm. Suppl.561–29. 10.1007/978-3-7091-6360-3_1
70
JellingerK. A. (2011). Synuclein deposition and non-motor symptoms in Parkinson disease.J. Neurol. Sci.310107–111. 10.1016/j.jns.2011.04.012
71
JonesC. R.JahanshahiM. (2013). Contributions of the basal ganglia to temporal processing: evidence from Parkinson’s disease.Timing Time Percept.11–41.
72
JonesC. R. G.ClaassenD. O.YuM.SpiesJ. R.MaloneT.DirnbergerG.et al (2011). Modeling accuracy and variability of motor timing in treated and untreated Parkinson’s disease and healthy controls.Front. Integr. Neurosci.5:81. 10.3389/fnint.2011.00081
73
JuradoM. B.RosselliM. (2007). The elusive nature of executive functions: a review of our current understanding.Neuropsychol. Rev.17213–233. 10.1007/s11065-007-9040-z
74
KaasinenV.NurmiE.BrückA.EskolaO.BergmanJ.SolinO.et al (2001). Increased frontal [(18)F]fluorodopa uptake in early Parkinson’s disease: sex differences in the prefrontal cortex.Brain1241125–1130. 10.1093/brain/124.6.1125
75
KehagiaA. A.MurrayG. K.RobbinsT. W. (2010). Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation.Curr. Opin. Neurobiol.20199–204. 10.1016/j.conb.2010.01.007
76
KimJ.GhimJ.-W.LeeJ. H.JungM. W. (2013). Neural correlates of interval timing in rodent prefrontal cortex.J. Neurosci.3313834–13847. 10.1523/JNEUROSCI.1443-13.2013
77
KobayashiS.SchultzW. (2008). Influence of reward delays on responses of dopamine neurons.J. Neurosci.287837–7846. 10.1523/JNEUROSCI.1600-08.2008
78
KochG.BrusaL.OliveriM.StanzioneP.CaltagironeC. (2005). Memory for time intervals is impaired in left hemi-Parkinson patients.Neuropsychologia431163–1167. 10.1016/j.neuropsychologia.2004.11.017
79
KochG.CostaA.BrusaL.PeppeA.GattoI.TorrieroS.et al (2008). Impaired reproduction of second but not millisecond time intervals in Parkinson’s disease.Neuropsychologia461305–1313. 10.1016/j.neuropsychologia.2007.12.005
80
KurtiA. N.MatellM. S. (2011). Nucleus accumbens dopamine modulates response rate but not response timing in an interval timing task.Behav. Neurosci.125215–225. 10.1037/a0022892
81
LajeR.BuonomanoD. V. (2013). Robust timing and motor patterns by taming chaos in recurrent neural networks.Nat. Neurosci.16925–933. 10.1038/nn.3405
82
LakeJ. I.MeckW. H. (2013). Differential effects of amphetamine and haloperidol on temporal reproduction: dopaminergic regulation of attention and clock speed.Neuropsychologia51284–292. 10.1016/j.neuropsychologia.2012.09.014
83
LapishC. C.KroenerS.DurstewitzD.LavinA.SeamansJ. K. (2007). The ability of the mesocortical dopamine system to operate in distinct temporal modes.Psychopharmacology (Berl.)191609–625. 10.1007/s00213-006-0527-8
84
LevyG.JacobsD. M.TangM.-X.CôtéL. J.LouisE. D.AlfaroB.et al (2002a). Memory and executive function impairment predict dementia in Parkinson’s disease.Mov. Disord.171221–1226. 10.1002/mds.10280
85
LevyG.TangM. -X.LouisE. D.CôtéL. J.AlfaroB.MejiaH.et al (2002b). The association of incident dementia with mortality in PD.Neurology591708–1713. 10.1212/01.WNL.0000036610.36834.E0
86
LezakM. D.HowiesonD. B.LoringD. W. (2004). Neuropsychological Assessment, 4th Edn.New York, NY: Oxford University Press.
87
LoosM.PattijT.JanssenM. C. W.CounotteD. S.SchoffelmeerA. N. M.SmitA. B.et al (2010). Dopamine receptor D1/D5 gene expression in the medial prefrontal cortex predicts impulsive choice in rats.Cereb. Cortex201064–1070. 10.1093/cercor/bhp167
88
LudvigE. A.BalciF.SpetchM. L. (2011). Reward magnitude and timing in pigeons.Behav. Processes86359–363. 10.1016/j.beproc.2011.01.003
89
MahieuxF.FénelonG.FlahaultA.ManifacierM. J.MicheletD.BollerF. (1998). Neuropsychological prediction of dementia in Parkinson’s disease.J. Neurol. Neurosurg. Psychiatry64178–183. 10.1136/jnnp.64.2.178
90
MalapaniC.DeweerB.GibbonJ. (2002). Separating storage from retrieval dysfunction of temporal memory in Parkinson’s disease.J. Cogn. Neurosci.14311–322. 10.1162/089892902317236920
91
MalapaniC.RakitinB.LevyR.MeckW. H.DeweerB.DuboisB.et al (1998). Coupled temporal memories in Parkinson’s disease: a dopamine-related dysfunction.J. Cogn. Neurosci.10316–331. 10.1162/089892998562762
92
MaricqA. V.ChurchR. M. (1983). The differential effects of haloperidol and methamphetamine on time estimation in the rat.Psychopharmacology7910–15. 10.1007/BF00433008
93
MatellM. S.MeckW. HNicolelisM. A. L. (2003). Interval timing and the encoding of signal duration by ensembles of cortical and striatal neurons.Behav. Neurosci.117760–773. 10.1037/0735-7044.117.4.760
94
McCormickD. A.SteinmetzJ. E.ThompsonR. F. (1985). Lesions of the inferior olivary complex cause extinction of the classically conditioned eyeblink response.Brain Res.359120–130. 10.1016/0006-8993(85)91419-2
95
MeckW. H. (2006). Neuroanatomical localization of an internal clock: a functional link between mesolimbic, nigrostriatal, and mesocortical dopaminergic systems.Brain Res.110993–107. 10.1016/j.brainres.2006.06.031
96
MeckW. H.ChurchR. M. (1987). Cholinergic modulation of the content of temporal memory.Behav. Neurosci.101457–464. 10.1037/0735-7044.101.4.457
97
MeckW. H.PenneyT. B.PouthasV. (2008). Cortico-striatal representation of time in animals and humans.Curr. Opin. Neurobiol.18145–152. 10.1016/j.conb.2008.08.002
98
MehannaR.JankovicJ. (2013). Movement disorders in cerebrovascular disease.Lancet Neurol.12597–608. 10.1016/S1474-4422(13)70057-7
99
MerchantH.HarringtonD. L.MeckW. H. (2013). Neural basis of the perception and estimation of time.Annu. Rev. Neurosci.36313–336. 10.1146/annurev-neuro-062012-170349
100
MerchantH.LucianaM.HooperC.MajesticS.TuiteP. (2008). Interval timing and Parkinson’s disease: heterogeneity in temporal performance.Exp. Brain Res.184233–248. 10.1007/s00221-007-1097-7
101
MillerE. K.CohenJ. D. (2001). An integrative theory of prefrontal cortex function.Annu. Rev. Neurosci.24167–202. 10.1146/annurev.neuro.24.1.167
102
MirabellaG.IaconelliS.ModugnoN.GianniniG.LenaF.CantoreG. (2013). Stimulation of subthalamic nuclei restores a near normal planning strategy in Parkinson’s patients.PLoS ONE8:e62793. 10.1371/journal.pone.0062793
103
MitaA.MushiakeH.ShimaK.MatsuzakaY.TanjiJ. (2009). Interval time coding by neurons in the presupplementary and supplementary motor areas.Nat. Neurosci.12502–507. 10.1038/nn.2272
104
MorrisonC. E.BorodJ. C.BrinM. F.HälbigT. D.OlanowC. W. (2004). Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson’s disease (MSPD).J. Neural Transm.1111333–1341. 10.1007/s00702-004-0145-8
105
NarayananN. S.LandB. B.SolderJ. E.DeisserothK.DileoneR. J. (2012). Prefrontal D1 dopamine signaling is required for temporal control.Proc. Natl. Acad. Sci. U.S.A. 10.1073/pnas.1211258109
106
NarayananN. S.LaubachM. (2006). Top-down control of motor cortex ensembles by dorsomedial prefrontal cortex.Neuron52921–931. 10.1016/j.neuron.2006.10.021
107
NarayananN. S.LaubachM. (2009). Delay activity in rodent frontal cortex during a simple reaction time task.J. Neurophysiol.1012859–2871. 10.1152/jn.90615.2008
108
NikiH.WatanabeM. (1979). Prefrontal and cingulate unit activity during timing behavior in the monkey.Brain Res.171213–224. 10.1016/0006-8993(79)90328-7
109
NormanT.ShalliceD. (1986). “Attention to action: willed and automatic control of behavior,” inConsciousness and Self-Regulation: Advances in Research and TheoryedsDavidsonR. J.ShwartzG. E.ShapiroD. (New York: Plenum) 1–18.
110
O’BoyleD. J.FreemanJ. S.CodyF. W. (1996). The accuracy and precision of timing of self-paced, repetitive movements in subjects with Parkinson’s disease.Brain 119(Pt1)51–70. 10.1093/brain/119.1.51
111
OgdenR. S.SalominaiteE.JonesL. A.FiskJ. E.MontgomeryC. (2011). The role of executive functions in human prospective interval timing.Acta Psychol. (Amst.)137352–358. 10.1016/j.actpsy.2011.04.004
112
OltonD. S.WenkG. L.ChurchR. M.MeckW. H. (1988). Attention and the frontal cortex as examined by simultaneous temporal processing.Neuropsychologia26307–318. 10.1016/0028-3932(88)90083-8
113
Pascual-SedanoB.KulisevskyJ.BarbanojM.Garcïa-SánchezC.CampolongoA.GironellA.et al (2008). Levodopa and executive performance in Parkinson’s disease: a randomized study.J. Int. Neuropsychol. Soc.14832–841. 10.1017/S1355617708081010
114
PastorM. A.ArtiedaJ.JahanshahiM.ObesoJ. A. (1992). Time estimation and reproduction is abnormal in Parkinson’s disease.Brain 115(Pt1)211–225. 10.1093/brain/115.1.211
115
PerbalS.DeweerB.PillonB.VidailhetM.DuboisB.PouthasV. (2005). Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson’s disease.Brain Cogn.5835–48. 10.1016/j.bandc.2005.02.003
116
PhillipsA. G.AhnS.FlorescoS. B. (2004). Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task.J. Neurosci.24547–553. 10.1523/JNEUROSCI.4653-03.2004
117
PictonT. W.StussD. T.AlexanderM. P.ShalliceT.BinnsM. A.GillinghamS. (2006). Effects of focal frontal lesions on response inhibition.Cereb. Cortex17826–838. 10.1093/cercor/bhk031
118
PoeweW.WoltersE.EmreM.OnofrjM.HsuC.TekinS.et al (2006). Long-term benefits of rivastigmine in dementia associated with Parkinson’s disease: an active treatment extension study.Mov. Disord.21456–461. 10.1002/mds.20700
119
PraamstraP.PopeP. (2007). Slow brain potential and oscillatory EEG manifestations of impaired temporal preparation in Parkinson’s disease.J. Neurophysiol.982848–2857. 10.1152/jn.00224.2007
120
RakshiJ. S.UemaT.ItoK.BaileyD. L.MorrishP. K.AshburnerJ.et al (1999). Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson’s disease A 3D [(18)F]dopa-PET study.Brain 122(Pt9)1637–1650. 10.1093/brain/122.9.1637
121
RattatA. C. (2010). Bidirectional interference between timing and concurrent memory processing in children.J. Exp. Child Psychol.106145–162. 10.1016/j.jecp.2010.02.001
122
RiesenJ. M.SchniderA. (2001). Time estimation in Parkinson’s disease: normal long duration estimation despite impaired short duration discrimination.J. Neurol.24827–35. 10.1007/s004150170266
123
SantangeloG.TrojanoL.VitaleC.IannicielloM.AmboniM.GrossiD.et al (2007). A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations.Mov. Disord.222418–2425. 10.1002/mds.21746
124
SawadaY.NishioY.SuzukiK.HirayamaK.TakedaA.HosokaiY.et al (2012). Attentional set-shifting deficit in Parkinson’s disease is associated with prefrontal dysfunction: an FDG-PET study.PLoS ONE7:e38498. 10.1371/journal.pone.0038498
125
ScattonB.Javoy-AgidF.RouquierL.DuboisB.AgidY. (1983). Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson’s disease.Brain Res.275321–328. 10.1016/0006-8993(83)90993-9
126
SchneiderB. A.GhoseG. M. (2012). Temporal production signals in parietal cortex.PLoS Biol.10:e1001413. 10.1371/journal.pbio.1001413
127
SeamansJ. K.FlorescoS. B.PhillipsA. G. (1998). D1 receptor modulation of hippocampal–prefrontal cortical circuits integrating spatial memory with executive functions in the rat.J. Neurosci.181613–1621.
128
SeamansJ. K.YangC. R. (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex.Prog. Neurobiol.741–58. 10.1016/j.pneurobio.2004.05.006
129
ShethS. A.MianM. K.PatelS. R.AsaadW. F.WilliamsZ. M.DoughertyD. D.et al (2012). Human dorsal anterior cingulate cortex neurons mediate ongoing behavioural adaptation.Nature488218–221. 10.1038/nature11239
130
ShimamuraA. P.JanowskyJ. S.SquireL. R. (1990). Memory for the temporal order of events in patients with frontal lobe lesions and amnesic patients. Neuropsychologia28803–813. 10.1016/0028-3932(90)90004-8
131
SimenP.BalciF.de SouzaL.CohenJ. D.HolmesP. (2011). A model of interval timing by neural integration.J. Neurosci.319238–9253. 10.1523/JNEUROSCI.3121-10.2011
132
SternbergD. A.BallardK.HardyJ. L.KatzB.DoraiswamyP. M.ScanlonM. (2013). The largest human cognitive performance dataset reveals insights into the effects of lifestyle factors and aging.Front. Hum. Neurosci.7:292. 10.3389/fnhum.2013.00292
133
StussD. T.AlexanderM. P.ShalliceT.PictonT. W.BinnsM. A.MacdonaldR.et al (2005). Multiple frontal systems controlling response speed.Neuropsychologia43396–417. 10.1016/j.neuropsychologia.2004.06.010
134
TakahashiH.YamadaM.SuharaT. (2012). Functional significance of central D1 receptors in cognition: beyond working memory.J. Cereb. Blood Flow Metab.321248–1258. 10.1038/jcbfm.2011.194
135
TaylorK. M.HorvitzJ. C.BalsamP. D. (2007). Amphetamine affects the start of responding in the peak interval timing task.Behav. Processes74168–175. 10.1016/j.beproc.2006.11.005
136
TortaD. M. E.CastelliL.Latini-CorazziniL.BancheA.LopianoL.GeminianiG. (2010). Dissociation between time reproduction of actions and of intervals in patients with Parkinson’s disease.J. Neurol.2571356–1361. 10.1007/s00415-010-5532-5
137
UcE. Y.RizzoM.AndersonS. W.QianS.RodnitzkyR. L.DawsonJ. D. (2005). Visual dysfunction in Parkinson disease without dementia.Neurology651907–1913. 10.1212/01.wnl.0000191565.11065.11
138
Van SpaendonckK. P.BergerH. J.HorstinkM. W.BuytenhuijsE. L.CoolsA. R. (1996). Executive functions and disease characteristics in Parkinson’s disease.Neuropsychologia34617–626. 10.1016/0028-3932(95)00159-X
139
WangM.VijayraghavanS.Goldman-RakicP. S. (2004). Selective D2 receptor actions on the functional circuitry of working memory.Science303853–856. 10.1126/science.1091162
140
WhitehouseP. J.HedreenJ. C.WhiteC. L.PriceD. L. (1983). Basal forebrain neurons in the dementia of Parkinson disease.Ann. Neurol.13243–248. 10.1002/ana.410130304
141
Wild-WallN.WillemssenR.FalkensteinM.BesteC. (2008). Time estimation in healthy ageing and neurodegenerative basal ganglia disorders.Neurosci. Lett.44234–38. 10.1016/j.neulet.2008.06.069
142
WilliamsG. V.Goldman-RakicP. S. (1995). Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.Nature376572–575. 10.1038/376572a0
143
WilliamsS. M.Goldman-RakicP. S. (1998). Widespread origin of the primate mesofrontal dopamine system.Cereb. Cortex8321–345. 10.1093/cercor/8.4.321
144
Williams-GrayC. H.EvansJ. R.GorisA.FoltynieT.BanM.RobbinsT. W.et al (2009). The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort.Brain1322958–2969. 10.1093/brain/awp245
145
Williams-GrayC. H.FoltynieT.BrayneC. E. G.RobbinsT. W.BarkerR. A. (2007). Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort.Brain1301787–1798. 10.1093/brain/awm111
146
WylieS. A.RidderinkhofK. R.EliasW. J.FrysingerR. C.BashoreT. R.DownsK. E.et al (2010). Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson’s disease.Brain1333611–3624. 10.1093/brain/awq239
147
WylieS. A.van den WildenbergW.RidderinkhofK. R.ClaassenD. O.WootenG. F.ManningC. A. (2012). Differential susceptibility to motor impulsivity among functional subtypes of Parkinson’s disease.J. Neurol. Neurosurg. Psychiatry831149–1154. 10.1136/jnnp-2012-303056
148
ZesiewiczT. A.SullivanK. L.ArnulfI.ChaudhuriK. R.MorganJ. C.GronsethG. S.et al (2010). Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology74924–931. 10.1212/WNL.0b013e3181d55f24
149
ZetterströmT.SharpT.MarsdenC. A.UngerstedtU. (1983). In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.J. Neurochem.411769–1773. 10.1111/j.1471-4159.1983.tb00893.x
Summary
Keywords
temporal processing, executive function, cognitive impairment, Parkinson’s disease, interval timing
Citation
Parker KL, Lamichhane D, Caetano MS and Narayanan NS (2013) Executive dysfunction in Parkinson’s disease and timing deficits. Front. Integr. Neurosci. 7:75. doi: 10.3389/fnint.2013.00075
Received
30 July 2013
Accepted
14 October 2013
Published
31 October 2013
Volume
7 - 2013
Edited by
Warren H. Meck, Duke University, USA
Reviewed by
Vinay V. Parikh, Temple University, USA; Daniel Claassen, Vanderbilt University, USA
Copyright
© 2013 Parker, Lamichhane, Caetano and Narayanan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nandakumar S. Narayanan, Department of Neurology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52243, USA e-mail: nandakumar-narayanan@uiowa.edu
This article was submitted to the journal Frontiers in Integrative Neuroscience.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.